paclitaxel has been researched along with Cancer, Second Primary in 43 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (4.65) | 18.2507 |
| 2000's | 20 (46.51) | 29.6817 |
| 2010's | 14 (32.56) | 24.3611 |
| 2020's | 7 (16.28) | 2.80 |
| Authors | Studies |
|---|---|
| Adhav, R; An, T; Chan, UI; Deng, CX; Lei, JH; Li, J; Liu, J; Miao, K; Mo, L; Shu, X; Su, SM; Wang, Y; Xu, J; Xu, X; Zhang, X | 1 |
| Al-Batran, SE; Ettrich, T; Goetze, TO; Gökkurt, E; Hinke, A; Lordick, F; Lorenzen, S; Pauligk, C; Pink, D; Probst, S; Reichardt, P; Sökler, M; Stahl, M; Thuss-Patience, P | 1 |
| Akhmedzhanov, F; Brink, AL; Carter, B; Coleman, RL; Fu, S; Gershenson, D; Gong, J; Hong, DS; Jazaeri, A; Leung, CH; Lin, H; McQuinn, L; Meric-Bernstam, F; Naing, A; Pant, S; Piha-Paul, S; Shah, J; Sood, AK; Tsimberidou, A; Westin, SN; Yilmaz, B | 1 |
| Chen, L; Cui, M; Liu, M; Su, X; Tan, F; Wu, B; Xing, J; Xu, K; Yang, H; Yao, Z; Zhang, C; Zhang, N | 1 |
| Chakraborty, K; Costello, PN; Manthri, S; Rehman, HH | 1 |
| Anand, K; Chiang, S; Duvic, M; Ensor, J; Hwu, P; Iyer, S; Miranda, R; Pingali, SR; Zu, Y | 1 |
| Baste, N; Even, C; Herrera Gómez, RG; Iacob, M; Mayache, L; Saleh, K | 1 |
| Dasanu, CA; Hyams, DM; Senatore, FJ | 1 |
| Belille, E; Brenner, JC; Carey, TE; Goudsmit, CM; Marchiano, E; McHugh, JB; Shuman, AG; Spector, ME; VanKoevering, KK; Walline, HM | 1 |
| Carlesimo, M; Caro, G; Cortesi, E; D'Arino, A; Fortuna, CM; Grifalchi, F; Pigliacelli, F; Rossi, A; Zancla, S | 1 |
| Kimura, D; Masuda, T; Nakashima, Y; Narazaki, T; Ogawa, Y; Ohshima, K; Shiratsuchi, M; Takamatsu, A; Tsuda, M; Tsukamoto, Y | 1 |
| Bachert, SE; Gibbs, R; Ginter, PS; Stewart, RL | 1 |
| Iida, K; Ishibashi, T; Ishikawa, M; Katagiri, A; Katagiri, H; Miyazaki, K; Nakayama, K; Nakayama, N; Rahman, M; Rahman, MT | 1 |
| Chandra, H; Chandra, S; Verma, SK | 1 |
| Dartigues, P | 1 |
| Kumar, PV; Prabaharan, S; Ravind, R | 1 |
| Chang, CL; Chen, JH; Chen, TM; Lai, MT; Lee, FP; Lin, KC; Wu, CC; Wu, SY; Yen, YC; Yuan, KS | 1 |
| Hirabayashi, K; Hirasawa, T; Kajiwara, H; Kumaki, N; Mikami, M; Miyazawa, M; Muramatsu, T; Nakamura, N; Osamura, RY; Yasuda, M | 1 |
| Amorós, A; Casinello, J; Heredia, M; Lázaro, A; López-Alfonso, A | 1 |
| Abe, A; Ikawa, H; Maeda, Y; Muguruma, H | 1 |
| Halle, J; Hayes, DN; Lee, CB; Moore, DT; Morris, DE; Rivera, MP; Rosenman, JG; Socinski, MA; Stinchcombe, TE | 1 |
| Irie, T; Mori, A; Morioka, M; Saito, M; Tanaka, M | 1 |
| Im, DD; Matsuo, K; Rosenshein, NB | 1 |
| Hirano, K; Kajiwara, H; Miyahara, S; Sugiyama, S | 1 |
| Foretová, L; Fridrichová, P; Laco, J; Melichar, B; Papajík, T; Simkovič, M | 1 |
| Dasanu, CA; Kaur, A | 1 |
| Christodoulou, J; Haferlach, T; Schnittger, S; Schoch, C | 1 |
| Damon, L; Demirer, T; Derigs, G; Ferrante, P; Kröger, N; Rosti, G; Wandt, H; Zander, AR | 1 |
| Abe, T; Kakazu, N; Matsuhashi, Y; Nagai, M; Tamura, T; Tasaka, T; Uehara, E | 1 |
| Boehlke, I; Bokemeyer, C; Hartmann, JT; Kanz, L; Kollmannsberger, C; Kuczyk, M; Metzner, B; Schleicher, J; Schleucher, N; Wierecky, J | 1 |
| Argiris, A; Haraf, DJ; Kao, J; Milano, MT; Mittal, BB; Salama, JK; Stenson, KM; Vokes, EE; Weichselbaum, RR; Witt, ME | 1 |
| Berman, ML; Burger, RA; Disaia, PJ; Fruehauf, JP; Kyshtoobayeva, AS; Manetta, A; Mehta, RS; Monk, BJ; Tewari, KS; Yu, IR | 1 |
| Burges, A; du Bois, A; Gropp, M; Harter, P; Huober, J; Pfisterer, J; Schade-Brittinger, C; Schmalfeldt, B; Staehle, A; Wollschlaeger, K | 1 |
| Deutsch, M; Werner, R | 1 |
| Chmura, SJ; Haraf, DJ; Kao, J; Milano, MT; Salama, JK; Stenson, KM; Vokes, EE; Witt, ME | 1 |
| Arano Bermejo, JI; Cabañas Navarro, L; Capote Armas, LF; González-Palacios Martínez, F; Reguero Callejas, ME; Ruiz Tovar, J | 1 |
| Li, Y; Machtay, M; Wong, SJ | 1 |
| Berry, DA; Budman, DR; Cirrincione, C; Citron, ML; Henderson, IC; Hudis, CA; Muss, HB; Norton, L; Winer, EP | 1 |
| Bafaloukos, D; Briasoulis, E; Dafni, U; Dimitrakakis, K; Dimopoulos, AM; Fountzilas, G; Gogas, H; Kalofonos, HP; Karanikiotis, C; Karina, M; Linardou, H; Makrantonakis, P; Markopoulos, C; Papadimitriou, C; Papakostas, P; Pectasides, D; Pisanidis, N; Polichronis, A; Samantas, E; Skarlos, D; Stathopoulos, GP; Tzorakoeleftherakis, E; Varthalitis, I; Xiros, N | 1 |
| Bontenbal, M; de Wit, R; Klijn, JG; Seynaeve, C | 1 |
| Campbell, LJ; Ellims, PH; Estey, EH; Juneja, SK; Prince, HM; Seymour, JF | 1 |
| De Giorgi, U; Marangolo, M; Papiani, G; Rosti, G | 1 |
| Baba, H; Hoffmeier, A; Kamanabrou, D; Roos, N; Rothenburger, M; Scheld, HH; Schmidt, C; Semik, M | 1 |
9 review(s) available for paclitaxel and Cancer, Second Primary
| Article | Year |
|---|---|
T-cell lymphoma secondary to checkpoint inhibitor therapy.
Topics: Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Transitional Cell; Humans; Immunotherapy; Lymphoma, T-Cell; Male; Neoplasms, Second Primary; Paclitaxel; Pleural Neoplasms; Prognosis; Urinary Bladder Neoplasms | 2020 |
[Peritoneal tumor pathology - case no. 3 : peritoneal well-differentiated papillary mesothelioma].
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Camptothecin; Carboplatin; Combined Modality Therapy; Cystadenofibroma; Diagnosis, Differential; Female; Fluorouracil; Humans; Hyperthermia, Induced; Infusions, Parenteral; Irinotecan; Leucovorin; Mesothelioma; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Organoplatinum Compounds; Ovarian Neoplasms; Ovariectomy; Oxaliplatin; Paclitaxel; Pemetrexed; Peritoneal Neoplasms | 2015 |
Secondary acute leukemia following mitoxantrone-based high-dose chemotherapy for primary breast cancer patients.
Topics: Acute Disease; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Doxorubicin; Epirubicin; Female; Humans; Incidence; Leukemia, Myeloid; Leukemia, Myelomonocytic, Acute; Leukemia, Promyelocytic, Acute; Leukemia, Radiation-Induced; Lymphatic Metastasis; Melphalan; Middle Aged; Mitoxantrone; Neoplasms, Second Primary; Paclitaxel; Peripheral Blood Stem Cell Transplantation; Radiotherapy, Adjuvant; Thiotepa; Transplantation Conditioning; Transplantation, Autologous | 2003 |
Secondary acute monocytic leukemia with a translocation t(8;16)(p11;p13): case report and review of the literature.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cell Transformation, Neoplastic; Chromosomes, Human, Pair 16; Chromosomes, Human, Pair 8; Female; Humans; Leukemia, Monocytic, Acute; Neoplasms, Second Primary; Ovarian Neoplasms; Paclitaxel; Translocation, Genetic | 2004 |
Angiosarcoma of the breast with delay in diagnosis.
Topics: Angiogenesis Inhibitors; Antineoplastic Agents, Phytogenic; Biopsy; Breast Neoplasms; Carcinoma; Diagnosis, Differential; Early Diagnosis; False Negative Reactions; Fatal Outcome; Female; Hemangiosarcoma; Humans; Lymph Node Excision; Mastectomy, Segmental; Middle Aged; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Paclitaxel; Pigmentation Disorders; Radiodermatitis; Radiotherapy, Adjuvant; Telangiectasis | 2004 |
Locally recurrent, previously irradiated head and neck cancer: concurrent re-irradiation and chemotherapy, or chemotherapy alone?
Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Cisplatin; Fluorouracil; Head and Neck Neoplasms; Humans; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Paclitaxel; Patient Selection; Randomized Controlled Trials as Topic; Risk Assessment; Salvage Therapy; Survival Analysis; Treatment Failure | 2006 |
[Chemotherapy in metastasized breast carcinoma].
Topics: Anthracyclines; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Docetaxel; Female; Humans; Neoplasm Metastasis; Neoplasms, Second Primary; Paclitaxel; Palliative Care; Quality of Life; Survival Rate; Taxoids | 1998 |
Secondary acute myeloid leukemia with inv(16): report of two cases following paclitaxel-containing chemotherapy and review of the role of intensified ara-C therapy.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Carcinoma, Neuroendocrine; Chromosome Inversion; Chromosomes, Human, Pair 16; Cytarabine; Dose-Response Relationship, Drug; Female; Humans; Leukemia, Myelomonocytic, Acute; Male; Middle Aged; Neoplasms, Second Primary; Ovarian Neoplasms; Paclitaxel; Prognosis; Treatment Outcome | 1999 |
The status of high-dose chemotherapy with hematopoietic stem cell transplantation in germ cell tumor patients.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cisplatin; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Cyclophosphamide; Etoposide; Europe; Forecasting; Gastrointestinal Diseases; Germinoma; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Hepatic Veno-Occlusive Disease; Humans; Ifosfamide; Kidney Diseases; Male; Multicenter Studies as Topic; Neoplasms, Second Primary; Paclitaxel; Prognosis; Randomized Controlled Trials as Topic; Salvage Therapy; Thiotepa; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome | 2002 |
6 trial(s) available for paclitaxel and Cancer, Second Primary
| Article | Year |
|---|---|
FOLFIRI plus ramucirumab versus paclitaxel plus ramucirumab as second-line therapy for patients with advanced or metastatic gastroesophageal adenocarcinoma with or without prior docetaxel - results from the phase II RAMIRIS Study of the German Gastric Can
Topics: Adenocarcinoma; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Humans; Neoplasms, Second Primary; Paclitaxel; Ramucirumab; Stomach Neoplasms | 2022 |
Selinexor in combination with weekly paclitaxel in patients with metastatic solid tumors: Results of an open label, single-center, multi-arm phase 1b study with expansion phase in ovarian cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Hydrazines; Male; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Ovarian Neoplasms; Paclitaxel | 2023 |
Late complications of high-dose (>/=66 Gy) thoracic conformal radiation therapy in combined modality trials in unresectable stage III non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Feasibility Studies; Female; Follow-Up Studies; Forced Expiratory Volume; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Second Primary; Paclitaxel; Prognosis; Radiotherapy Dosage; Radiotherapy, Conformal; Remission Induction; Retrospective Studies; Risk Factors; Survival Rate; Treatment Outcome | 2009 |
Twice-daily reirradiation for recurrent and second primary head-and-neck cancer with gemcitabine, paclitaxel, and 5-fluorouracil chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Deoxycytidine; Female; Fluorouracil; Gemcitabine; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Paclitaxel; Radiotherapy Dosage | 2005 |
Toxicity of older and younger patients treated with adjuvant chemotherapy for node-positive breast cancer: the Cancer and Leukemia Group B Experience.
Topics: Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Doxorubicin; Female; Humans; Leukemia, Myeloid, Acute; Lymphatic Metastasis; Middle Aged; Myelodysplastic Syndromes; Neoplasms, Second Primary; Paclitaxel | 2007 |
Postoperative dose-dense sequential chemotherapy with epirubicin, paclitaxel and CMF in patients with high-risk breast cancer: safety analysis of the Hellenic Cooperative Oncology Group randomized phase III trial HE 10/00.
Topics: Adult; Aged; Androstadienes; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Dose-Response Relationship, Drug; Epirubicin; Estrogens; Female; Fluorouracil; Granulocyte Colony-Stimulating Factor; Hematologic Diseases; Humans; Lymphatic Metastasis; Mastectomy; Methotrexate; Middle Aged; Neoplasms, Hormone-Dependent; Neoplasms, Second Primary; Paclitaxel; Peripheral Nervous System Diseases; Tamoxifen | 2008 |
28 other study(ies) available for paclitaxel and Cancer, Second Primary
| Article | Year |
|---|---|
ATP11B inhibits breast cancer metastasis in a mouse model by suppressing externalization of nonapoptotic phosphatidylserine.
Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Female; Humans; Melanoma; Melanoma, Cutaneous Malignant; Mice; Myeloid-Derived Suppressor Cells; Neoplasm Metastasis; Neoplasms, Second Primary; Paclitaxel; Phosphatidylserines; Skin Neoplasms; Tumor Microenvironment | 2022 |
The validity of neoadjuvant chemotherapy with paclitaxel plus S-1 is not inferior to that of SOX regimen for locally advanced gastric cancer: an observational study.
Topics: Humans; Neoadjuvant Therapy; Neoplasms, Second Primary; Paclitaxel; Postoperative Complications; Stomach Neoplasms | 2022 |
Thymic basaloid carcinoma: a rare clinical entity.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Female; Humans; Liver Neoplasms; Middle Aged; Neoplasms, Second Primary; Paclitaxel; Thymus Neoplasms | 2019 |
Panitumumab as an effective maintenance treatment in metastatic squamous cell carcinoma of the head and neck.
Topics: Anaphylaxis; Antineoplastic Agents; Antineoplastic Agents, Immunological; Carboplatin; Cetuximab; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Humans; Maintenance Chemotherapy; Male; Middle Aged; Neoplasms, Second Primary; Paclitaxel; Palliative Care; Panitumumab; Progression-Free Survival; Randomized Controlled Trials as Topic; Research Design; Squamous Cell Carcinoma of Head and Neck; Tongue Neoplasms | 2021 |
Adenocarcinoma of the appendix occurring in a patient treated with paclitaxel for locally advanced esophageal cancer.
Topics: Adenocarcinoma; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Appendiceal Neoplasms; Esophageal Neoplasms; Humans; Male; Neoplasms, Second Primary; Paclitaxel | 2018 |
An Algorithm to Evaluate Suspected Lung Metastases in Patients with HPV-Associated Oropharyngeal Cancer.
Topics: Algorithms; Antineoplastic Agents; Carboplatin; Combined Modality Therapy; Diagnosis, Differential; Female; Human papillomavirus 16; Humans; Immunohistochemistry; In Situ Hybridization; Lung Neoplasms; Male; Middle Aged; Neoplasms, Second Primary; Oropharyngeal Neoplasms; Paclitaxel; Papillomavirus Infections; Precision Medicine; Prospective Studies | 2018 |
Isochemotopic response: the first case on a scar.
Topics: Adenocarcinoma; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cicatrix; Cisplatin; Erythema; Humans; Lung Neoplasms; Male; Neoplasms, Second Primary; Paclitaxel; Thyroid Neoplasms; Thyroidectomy | 2020 |
Transformation of follicular lymphoma to double-hit lymphoma during adjuvant chemotherapy for concurrent ovarian carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Endometrioid; Chemotherapy, Adjuvant; Female; Humans; Lymphoma, Follicular; Middle Aged; Neoplasms, Second Primary; Ovarian Neoplasms; Paclitaxel | 2019 |
Metachronous cellular angiolipomas of the breast.
Topics: Aged; Angiolipoma; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Carcinoma, Ductal; Chemoradiotherapy, Adjuvant; Diagnosis, Differential; Female; Humans; Immunohistochemistry; Mastectomy, Modified Radical; Neoplasm Staging; Neoplasms, Second Primary; Paclitaxel; Ultrasonography, Mammary | 2019 |
Therapy-related myelodysplastic syndrome and acute myeloid leukemia following chemotherapy (paclitaxel and carboplatin) and radiation therapy in ovarian cancer: a case report.
Topics: Adrenal Gland Neoplasms; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Cerebral Infarction; Chemoradiotherapy; Fatal Outcome; Female; Humans; Leukemia, Myeloid, Acute; Liver Neoplasms; Myelodysplastic Syndromes; Neoplasms, Second Primary; Neoplastic Cells, Circulating; Ovarian Neoplasms; Paclitaxel | 2014 |
Multiple myeloma or metastatic carcinoma breast: diagnostic dilemma in a case presenting with lytic bony lesion.
Topics: Antineoplastic Agents; Bone Marrow Examination; Bortezomib; Breast Neoplasms; Carcinoma, Ductal, Breast; Dexamethasone; Doxorubicin; Fatal Outcome; Female; Humans; Mastectomy; Middle Aged; Multiple Myeloma; Neoplasm Staging; Neoplasms, Second Primary; Paclitaxel; Radiotherapy; Scapula | 2015 |
Inflammatory breast cancer in a previously treated case of breast cancer: a diagnostic dilemma for the clinician.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine; Female; Humans; Inflammatory Breast Neoplasms; Lapatinib; Middle Aged; Neoplasms, Second Primary; Paclitaxel; Prognosis; Quinazolines | 2016 |
Survival prognostic factors for metachronous second primary head and neck squamous cell carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Deoxycytidine; Docetaxel; Female; Fluorouracil; Gemcitabine; Head and Neck Neoplasms; Humans; Hydroxyurea; Male; Methotrexate; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Paclitaxel; Prognosis; Squamous Cell Carcinoma of Head and Neck; Survival Analysis; Taxoids; Treatment Outcome; Young Adult | 2017 |
A case of oncocytic carcinoma of the endometrium.
Topics: Adenocarcinoma; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Combined Modality Therapy; Endometrial Neoplasms; Female; Humans; Hysterectomy; Immunohistochemistry; Neoplasms, Second Primary; Paclitaxel | 2009 |
Bilateral inflammatory metachronic ERBB2 (HER2/neu)-positive breast carcinoma: prolonged survival with combined chemotherapy and trastuzumab.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine; Carcinoma, Ductal, Breast; Cisplatin; Deoxycytidine; Female; Fluorouracil; Humans; Mastectomy; Neoplasms, Second Primary; Paclitaxel; Receptor, ErbB-2; Remission Induction; Skin Neoplasms; Survival Rate; Trastuzumab | 2008 |
[Secondary myelodysplasia and leukemia following carboplatin and paclitaxel-containing chemotherapy for ovarian cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Female; Humans; Leukemia; Middle Aged; Myelodysplastic Syndromes; Neoplasms, Second Primary; Ovarian Neoplasms; Paclitaxel; Treatment Failure | 2008 |
[Therapy-related acute myeloid leukemia with 11q23 abnormality due to paclitaxel coexisting with bone marrow metastasis of breast cancer].
Topics: Antineoplastic Agents, Phytogenic; Bone Marrow Neoplasms; Breast Neoplasms; Chromosome Aberrations; Chromosomes, Human, Pair 11; Female; Humans; Leukemia, Myeloid, Acute; Middle Aged; Neoplasms, Second Primary; Paclitaxel | 2009 |
Increased paclitaxel resistance in recurrent epithelial ovarian cancer: analysis of metachronous tumors.
Topics: Antineoplastic Agents, Phytogenic; Chemotherapy, Adjuvant; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Female; Humans; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Ovarian Neoplasms; Paclitaxel; Time Factors | 2010 |
[A case of metachronous double primary adenocarcinoma in both lungs].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Humans; Lung Neoplasms; Male; Neoadjuvant Therapy; Neoplasms, Second Primary; Paclitaxel; Thoracotomy; Tomography, X-Ray Computed | 2010 |
Therapy-related myeloid neoplasms in epithelial ovarian cancer patients carrying BRCA1 mutation: report of two cases.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ovarian Epithelial; Cystadenocarcinoma, Serous; Fatal Outcome; Female; Genes, BRCA1; Heterozygote; Humans; Leukemia, Myeloid, Acute; Middle Aged; Mutation; Neoplasms, Glandular and Epithelial; Neoplasms, Second Primary; Ovarian Neoplasms; Paclitaxel; Platinum | 2012 |
Rapidly progressive colonic dysplasia/neoplasia in a series of treated lung cancer patients: Is paclitaxel involved?
Topics: Aged, 80 and over; Antineoplastic Agents, Phytogenic; Colonic Neoplasms; Colonic Polyps; Female; Humans; Immunosuppressive Agents; Lung Neoplasms; Male; Middle Aged; Neoplasms, Second Primary; Paclitaxel; Precancerous Conditions | 2013 |
Myelodysplastic syndrome (RARS) with +i(12p) abnormality in a patient 10 months after diagnosis and successful treatment of a mediastinal germ cell tumor (MGCT).
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chromosomes, Human, Pair 12; Cisplatin; Etoposide; Humans; Ifosfamide; Male; Mediastinal Neoplasms; Myelodysplastic Syndromes; Neoplasms, Germ Cell and Embryonal; Neoplasms, Second Primary; Paclitaxel | 2004 |
Secondary leukemia after first-line high-dose chemotherapy for patients with advanced germ cell cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials, Phase II as Topic; Etoposide; Follow-Up Studies; Germany; Germinoma; Humans; Ifosfamide; Leukemia, Myeloid, Acute; Male; Mediastinal Neoplasms; Multicenter Studies as Topic; Myelodysplastic Syndromes; Neoplasms, Second Primary; Paclitaxel; Peripheral Blood Stem Cell Transplantation; Testicular Neoplasms; Translocation, Genetic; Transplantation, Autologous | 2005 |
Conservation of in vitro drug resistance patterns in epithelial ovarian carcinoma.
Topics: Cisplatin; Cyclophosphamide; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Female; Humans; Neoplasm Metastasis; Neoplasms, Multiple Primary; Neoplasms, Second Primary; Ovarian Neoplasms; Paclitaxel; Topotecan | 2005 |
Non-enrolment of ovarian cancer patients in clinical trials: reasons and background.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Clinical Trials as Topic; Female; Humans; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Neoplasms, Second Primary; Ovarian Neoplasms; Paclitaxel; Patient Participation; Patient Selection; Prospective Studies; Retrospective Studies; Topotecan | 2005 |
Long-term outcome of concurrent chemotherapy and reirradiation for recurrent and second primary head-and-neck squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Camptothecin; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Deoxycytidine; Female; Fluorouracil; Gemcitabine; Head and Neck Neoplasms; Humans; Hydroxyurea; Irinotecan; Male; Mandibular Diseases; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Osteoradionecrosis; Paclitaxel; Prognosis; Radiotherapy Dosage; Treatment Failure; Treatment Outcome | 2006 |
Malignant mixed Mullerian tumors.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Fatal Outcome; Female; Femoral Neoplasms; Humans; Hysterectomy; Ifosfamide; Ilium; Middle Aged; Mixed Tumor, Mullerian; Neoplasms, Second Primary; Ovariectomy; Paclitaxel; Palliative Care; Pelvic Neoplasms; Prognosis; Radiotherapy, Adjuvant; Sarcoma, Ewing; Spinal Neoplasms; Uterine Neoplasms | 2006 |
Coexistence of non-Hodgkin's lymphoma and non-small cell lung carcinoma: diagnosis and treatment.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bronchoscopy; Carboplatin; Carcinoma, Non-Small-Cell Lung; Humans; Lung Neoplasms; Lymphoma, Non-Hodgkin; Male; Neoplasms, Second Primary; Paclitaxel; Radiography | 2002 |